This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Duke University, Lipomics Technologies, Inc., Children's Hospital Research Center at Oakland. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2,085 
2 out of 3 
1 out of 77 
Years Active: 2012-2014
Title: Innovations of Rebecca Ann Baillie in Lipidomics
Introduction
Rebecca Ann Baillie is an accomplished inventor based in Woodland, CA, with a notable focus on lipidomics and its applications in understanding central nervous system (CNS) disorders and cardiovascular diseases. With two patents to her name, her work exemplifies the innovative spirit in the field of medical research and treatment.
Latest Patents
Baillie's latest patents delve into the practical implications of lipidomics. The first patent, titled "Lipidomics approaches for central nervous system disorders," explores how lipid metabolic profiling can aid in diagnosing and treating CNS disorders. This invention emphasizes personalized medicine by providing tools to identify which patients respond to specific therapies and how to tailor treatments based on individual lipidomic signatures. The second patent, "Lipidomic approaches to determining drug response phenotypes in cardiovascular disease," outlines a method for correlating lipid profiles with responses to statin treatments. This innovative approach allows for a better understanding of how different patients respond to therapies, thereby advancing cardiovascular treatment strategies.
Career Highlights
Baillie has made impactful contributions through her tenure at institutions like Duke University and Lipomics Technologies, Inc. Her extensive research background has laid the groundwork for her patents, reflecting her commitment to advancing healthcare through scientific innovation.
Collaborations
Throughout her career, Rebecca Ann Baillie has collaborated with prominent figures in her field, including Rima Kaddurah-Daouk and K Ranga Rama Krishnan. These collaborations have enriched her work and led to significant advancements in understanding lipid metabolism and its effects on health.
Conclusion
Rebecca Ann Baillie stands out as a vibrant innovator whose patents are paving the way for new diagnostic and therapeutic approaches in CNS and cardiovascular disorders. Her pioneering work in lipidomics not only highlights the importance of personalized medicine but also emphasizes the necessity of understanding lipid metabolism in advancing modern healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile